Intensive adherence counselling for HIV‐infected individuals failing second‐line antiretroviral therapy in Johannesburg, South Africa

Objective In resource-limited settings where genotypic drug resistance testing is rarely performed and poor adherence is the most common reason for treatment failure programmatic approaches to handling treatment failure are essential. This study was performed to describe one such approach to adherence optimization. Methods This was a single-arm study of patients on second-line protease inhibitor (PI)-based antiretroviral therapy (ART) with a HIV-1 RNA =400 copies/ml in Johannesburg South Africa between 1 March 2012 and 1 December 2013. Patients underwent enhanced adherence counselling. Those with improved adherence and a repeat viral load of >1000 copies/ml underwent HIV-1 drug resistance testing. We describe results using simple proportions and 95% confidence intervals. Results Of the 400 patients who underwent targeted adherence counselling after an elevated viral load on second-line ART 388 (97%) underwent repeat viral load testing. Most of these (n = 249; 64% 95% CI 59-69) resuppressed ( 400 copies/ml 11 switched to third line 5 were awaiting third line 4 had died and 13 were lost to follow-up. Among the unsuppressed 48 successfully underwent resistance testing with some resistance detected in most (41/48). Conclusions Most (64%) second-line treatment failure in this clinic is related to adherence and can be overcome with careful adherence support. Controlled interventions are needed to determine what the optimal approach is to improving second-line outcomes and reducing the need for third-line ART.